However, with TGFβ being a multifunctional cytokine critical for maintaining tissue homeostasis, on-target anti-TGF-β therapies have been associated with severe side effects, including cardiovascular toxicity and the formation of benign tumors [26]. The gene discussed is TGFB1; the disease is benign neoplasm.